I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 19 studies | 27% ± 11% | |
| mast cell | 15 studies | 38% ± 14% | |
| oligodendrocyte | 15 studies | 56% ± 18% | |
| microglial cell | 10 studies | 28% ± 10% | |
| macrophage | 10 studies | 32% ± 13% | |
| epithelial cell | 8 studies | 34% ± 21% | |
| oligodendrocyte precursor cell | 7 studies | 28% ± 11% | |
| T cell | 6 studies | 21% ± 4% | |
| natural killer cell | 6 studies | 21% ± 2% | |
| respiratory goblet cell | 6 studies | 36% ± 13% | |
| ciliated cell | 6 studies | 28% ± 11% | |
| astrocyte | 6 studies | 31% ± 13% | |
| club cell | 5 studies | 27% ± 11% | |
| dendritic cell | 5 studies | 23% ± 5% | |
| myeloid cell | 5 studies | 30% ± 8% | |
| endothelial cell of lymphatic vessel | 5 studies | 23% ± 7% | |
| squamous epithelial cell | 4 studies | 36% ± 17% | |
| plasma cell | 4 studies | 32% ± 7% | |
| fibroblast | 4 studies | 26% ± 8% | |
| lymphocyte | 4 studies | 32% ± 15% | |
| retinal cone cell | 4 studies | 22% ± 6% | |
| GABAergic neuron | 4 studies | 39% ± 10% | |
| glutamatergic neuron | 4 studies | 35% ± 12% | |
| goblet cell | 4 studies | 40% ± 31% | |
| monocyte | 4 studies | 30% ± 6% | |
| type I pneumocyte | 4 studies | 24% ± 7% | |
| type II pneumocyte | 4 studies | 22% ± 6% | |
| neuron | 4 studies | 40% ± 22% | |
| ionocyte | 3 studies | 25% ± 8% | |
| secretory cell | 3 studies | 27% ± 6% | |
| CD4-positive, alpha-beta T cell | 3 studies | 25% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 5% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 25% ± 2% | |
| glial cell | 3 studies | 27% ± 6% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 19% ± 3% | |
| hepatocyte | 3 studies | 46% ± 27% | |
| alveolar macrophage | 3 studies | 32% ± 7% | |
| basal cell | 3 studies | 33% ± 9% | |
| interneuron | 3 studies | 40% ± 19% | |
| renal principal cell | 3 studies | 26% ± 7% | |
| mucus secreting cell | 3 studies | 31% ± 8% |
